Recombinant swine epidermal growth protein (rrhEGF) is demonstrating increased interest as a promising strategy in the field of wound therapy. This active agent, created through recombinant technology, offers a strong https://recombinant-porcine-egf942345.jiliblog.com/99389493/synthetic-swine-epidermal-development-protein-a-powerful-tool-for-wound-regeneration